Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B
Editorial Group: Cochrane Hepato-Biliary Group
Published Online: 7 DEC 2011
Assessed as up-to-date: 2 NOV 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Njei B, Kumar S, Kongnyuy EJ. Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009522. DOI: 10.1002/14651858.CD009522.
- Publication Status: New
- Published Online: 7 DEC 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the benefits and harms of adefovir dipivoxil alone or in combination with other drugs, as compared with antiviral drugs, in the treatment of patients with chronic hepatitis B virus infection. We will exclude comparisons that are already studied in other Cochrane Reviews on antiviral drugs for HBV infection (Katz 2010).